市场调查报告书
商品编码
1379317
影像影像药物市场:按类型、类别、应用、适应症、最终用户划分 - 全球预测 2023-2030Imaging Agents Market by Type (Barium-based Contrast Media, Gadolinium-based Contrast Media, Iodinated Contrast Media), Group (Non-targeted Agents, Targeted Agents), Application, Indication, End-User - Global Forecast 2023-2030 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
影像成像试剂市场预计将从 2022 年的 91.8 亿美元增至 2030 年的 141.5 亿美元,预测期内年复合成长率为 5.55%。
全球影像影像药物市场
主要市场统计 | |
---|---|
市场金额:基准年 [2022] | 91.8亿美元 |
预计市场价值 [2023] | 96.5亿美元 |
预计市场量[2030] | 141.5亿美元 |
年复合成长率(%) | 5.55% |
FPNV定位矩阵是评估影像成像试剂市场的必备工具。透过分析与业务策略和产品满意度相关的关键指标来全面评估供应商。这使得使用者能够根据自己的具体资讯做出明智的决策。进阶分析将供应商分为四个像限,每个象限都有不同程度的成功:前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。这个富有洞察力的框架使决策者能够充满信心地驾驭市场。
市场占有率分析为供应商的市场形势提供了宝贵的见解。评估对整体收益、客户群和其他关键指标的影响可以全面了解公司的业绩及其面临的竞争环境。该分析还揭示了研究期间的竞争水平,例如市场占有率增长、碎片化、主导地位和行业整合。
1.市场渗透:提供有关市场动态和主要企业产品的全面资讯。
2. 市场开拓:详细分析新兴和成熟细分市场的渗透情况,以突显利润丰厚的商机。
3. 市场多元化:有关新产品发布、开拓地区、最新发展和投资的详细资讯。
4.竞争评估与资讯:对主要企业的市场占有率、策略、产品、认证、法规状况、专利状况、製造能力等进行综合评估。
5. 产品开发与创新:对未来技术、研发活动和突破性产品开发的智慧洞察。
1.影像诊断药物市场规模及预测如何?
2.影像试剂市场哪些产品、细分领域、应用和领域最具投资潜力?
3.影像诊断药物市场竞争策略的窗口是什么?
4.影像影像药物市场的最新技术趋势和法律规范是什么?
5.影像影像试剂市场主要厂商的市场占有率为何?
6.进入影像诊断药物市场合适的型态和策略手段是什么?
The Imaging Agents Market is projected to reach USD 14.15 billion by 2030 from USD 9.18 billion in 2022, at a CAGR of 5.55% during the forecast period.
Global Imaging Agents Market
KEY MARKET STATISTICS | |
---|---|
Base Year Value [2022] | USD 9.18 billion |
Estimated Year Value [2023] | USD 9.65 billion |
Forecast Year Value [2030] | USD 14.15 billion |
CAGR (%) | 5.55% |
This research report analyzes various sub-markets, forecasts revenues, and examines emerging trends in each category to provide a comprehensive outlook on the Imaging Agents Market.
Based on Type, market is studied across Barium-based Contrast Media, Gadolinium-based Contrast Media, Iodinated Contrast Media, and Microbubble Contrast Media. The Gadolinium-based Contrast Media is projected to witness significant market share during forecast period.
Based on Group, market is studied across Non-targeted Agents and Targeted Agents. The Non-targeted Agents is projected to witness significant market share during forecast period.
Based on Application, market is studied across Computed Tomography (CT), Diagnostic Radiopharmaceuticals, Magnetic Resonance Imaging (MRI), Ultrasound, and X-ray. The Computed Tomography (CT) is projected to witness significant market share during forecast period.
Based on Indication, market is studied across Cardiology, Gastrointestinal, Neurology, and Oncology. The Oncology is projected to witness significant market share during forecast period.
Based on End-User, market is studied across Ambulatory Surgical Centers, Diagnostic & Imaging Centers, and Hospitals. The Hospitals is projected to witness significant market share during forecast period.
Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas is projected to witness significant market share during forecast period.
The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.
The FPNV Positioning Matrix is an indispensable tool for assessing the Imaging Agents Market. It comprehensively evaluates vendors, analyzing key metrics related to Business Strategy and Product Satisfaction. This enables users to make informed decisions tailored to their specific needs. Through advanced analysis, vendors are categorized into four distinct quadrants, each representing a different level of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V). Be assured that this insightful framework empowers decision-makers to navigate the market with confidence.
The Market Share Analysis offers invaluable insights into the vendor landscape Imaging Agents Market. By evaluating their impact on overall revenue, customer base, and other key metrics, we provide companies with a comprehensive understanding of their performance and the competitive environment they confront. This analysis also uncovers the level of competition in terms of market share acquisition, fragmentation, dominance, and industry consolidation during the study period.
The report delves into recent significant developments in the Imaging Agents Market, highlighting leading vendors and their innovative profiles. These include AYTU BioScience, Inc., Bayer AG, Beijing Beilu Pharmaceutical Co., Ltd., Bracco S.p.A., Capella Imaging, Inc., Cardinal Health, Inc., Curium, GE HealthCare Technologies Inc., Guerbet SA, Hovione, Livealth Biopharma Pvt. Ltd., Miltenyi Biotec B.V. & Co. KG, nanoPET Pharma GmbH, Piramal Group, Rege Imaging & Cine Films Private Limited, Sotera Health LLC, and Trivitron Healthcare.
1. Market Penetration: It provides comprehensive information about key players' market dynamics and offerings.
2. Market Development: In-depth analysis of emerging markets and penetration across mature market segments, highlighting lucrative opportunities.
3. Market Diversification: Detailed information about new product launches, untapped geographies, recent developments, and investments.
4. Competitive Assessment & Intelligence: Exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of leading players.
5. Product Development & Innovation: Intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast for the Imaging Agents Market?
2. Which products, segments, applications, and areas hold the highest investment potential in the Imaging Agents Market?
3. What is the competitive strategic window for identifying opportunities in the Imaging Agents Market?
4. What are the latest technology trends and regulatory frameworks in the Imaging Agents Market?
5. What is the market share of the leading vendors in the Imaging Agents Market?
6. Which modes and strategic moves are suitable for entering the Imaging Agents Market?